Citations

Showing 10 of 108083 citations.

Palpitations and Asthenia Associated with Venlafaxine in a CYP2D6 Poor Metabolizer and CYP2C19 Intermediate Metabolizer
García, S. Gómez , Schuh, Michael J. , Cheema, Anvir, Atwal, Herjot, Atwal, Paldeep S. , Schuh, Michael, Atwal, Paldeep S

Mayo Clinic

Case Reports in Genetics | October 16, 2017 | Volume: 2017 | Issue: No issue available | Pages: 1-4

10.1155/2017/6236714 | PMID 29123929 Get It

Cardiotoxicity has been extensively reported in venlafaxine (VEN) overdoses. Asthenia is also among the common side effects described for this antidepressant. VEN is metabolized mainly by CYP2D6 and to a minor extent by CYP2C19 to the major active metabolite O-desmethylvenlafaxine (ODV). Altered pharmacokinetic parameters in patients with polymorphisms in the CYP2D6 and CYP2C19 genes that result in decreased enzymatic activity have been documented. Here we describe a patient case of VEN associated palpitations and asthenia. The patient takes VEN extended release 150 mg twice daily. Genotyping confirmed the patient is a poor metabolizer for CYP2D6 and an intermediate metabolizer for CYP2C19. We propose that the palpitations and asthenia are related to sustained VEN exposure due to reduced metabolism.
Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis
Okamoto, Kohji , Takada, Tadahiro , Strasberg, Steven M. , Asbun, Horacio J. , Endo, Itaru , Iwashita, Yukio , Hibi, Taizo , Pitt, Henry A. , Umezawa, Akiko , Asai, Koji , Hwang, Tsann‐Long , Mori, Yasuhisa , Huang, Wayne Shih‐Wei, Belli, Giulio, Dervenis, Christos, Yokoe, Masamichi, Kiriyama, Seiki , Itoi, Takao , Jagannath, P., Garden, O. James , Miura, Fumihiko, Wakabayashi, Go , Cherqui, Daniel , Santibáñes, Eduardo de , Shikata, Satoru , Noguchi, Yoshinori , Higuchi, Ryota , Wada, Keita, Supe, Avinash , Yoshida, Masahiro , Mayumi, Toshihiko , Gouma, Dirk J., Deziel, Daniel J., Liau, Kui‐Hin, Chen, Miin‐Fu , Shibao, Kazunori , Liu, Keng‐Hao, Su, Cheng‐Hsi, Chan, Angus C. W., Choi, In‐Seok , Jonas, Eduard , Fan, Sheung Tat , Ker, Chen‐Guo , Giménez, Mariano , Kitano, Seigo, Inomata, Masafumi , Inui, Kazuo, Sumiyama, Yoshinobu, Yamamoto, Masakazu , Suzuki, Kenji S. , Han, Ho-Seong , Yoon, Yoo-Seok , Nakamura, Masafumi , Horiguchi, Akihiko , Ukai, Tomohiko , Honda, Goro , Yoon, Dong Sup , Chen, Xiaoping , Hirata, Koichi , Jonas, Eduard

Mayo Clinic

Journal of Hepato-Biliary-Pancreatic Sciences | October 16, 2017 | Volume: 25 | Issue: 1 | Pages: 55-72

10.1002/jhbp.516 | PMID 29045062 Get It

Abstract We propose a new flowchart for the treatment of acute cholecystitis ( AC ) in the Tokyo Guidelines 2018 (TG18). Grade III AC was not indicated for straightforward laparoscopic cholecystectomy (Lap‐C). Following analysis of subsequent clinical investigations and drawing on Big Data in particular, TG 18 proposes that some Grade III AC can be treated by Lap‐C when performed at advanced centers with specialized surgeons experienced in this procedure and for patients that satisfy certain strict criteria. For Grade I, TG 18 recommends early Lap‐C if the patients meet the criteria of Charlson comorbidity index ( CCI ) ≤5 and American Society of Anesthesiologists physical status classification ( ASA ‐ PS ) ≤2. For Grade II AC , if patients meet the criteria of CCI ≤5 and ASA ‐ PS ≤2, TG 18 recommends early Lap‐C performed by experienced surgeons; and if not, after medical treatment and/or gallbladder drainage, Lap‐C would be indicated. TG 18 proposes that Lap‐C is indicated in Grade III patients with strict criteria. These are that the patients have favorable organ system failure, and negative predictive factors, who meet the criteria of CCI ≤3 and ASA ‐ PS ≤2 and who are being treated at an advanced center (where experienced surgeons practice). If the patient is not considered suitable for early surgery, TG 18 recommends early/urgent biliary drainage followed by delayed Lap‐C once the patient's overall condition has improved. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47 . Related clinical questions and references are also included.
Employee health-relevant personality traits are associated with the psychosocial work environment and leadership
Villaume, Karin , Hasson, Dan , Hasson, Dan , Hasson, Dan

Mayo Clinic

International Journal of Occupational and Environmental Health | October 16, 2017 | Volume: 23 | Issue: 1 | Pages: 25-39

10.1080/10773525.2017.1386385 | PMID 29035168 Get It

Roles of kallikrein-2 biomarkers (free-hK2 and pro-hK2) for predicting prostate cancer progression-free survival
Guerrico, Anatilde González, Karnes, Jeffery, Gaston, Steven, Klee, George G., Hillman, David, Klee, George, Hillman, David W. , Davis, Brian J.

Mayo Clinic

Journal of Circulating Biomarkers | October 16, 2017 | Volume: 6 | Issue: No issue available | Pages: 184945441772015

10.1177/1849454417720151 | PMID 28936267 Get It

Clinical Use of a Home Sleep Apnea Test: An American Academy of Sleep Medicine Position Statement
Rosen, Ilene M. , Kirsch, Douglas B. , Chervin, Ronald D., Carden, Kelly A., Ramar, Kannan , Aurora, R. Nisha , Kristo, David A., Malhotra, Raman K. , Olson, Eric J. , Rosen, Carol L. , Rowley, James A. , Martin, Jennifer L.

Mayo Clinic

Journal of Clinical Sleep Medicine | October 16, 2017 | Volume: 13 | Issue: 10 | Pages: 1205-1207

10.5664/jcsm.6774 | PMID 28942762 Get It

American Academy of Sleep Medicine Position Paper for the Use of a Home Sleep Apnea Test for the Diagnosis of OSA in Children
Kirk, Valerie G., Baughn, Julie , D’Andrea, Lynn A., Galion, Anjalee , Garetz, Susan L. , Hassan, Fauziya, Wrede, Joanna E. , Harrod, Christopher G., Malhotra, Raman K. , Friedman, Norman R.

Mayo Clinic

Journal of Clinical Sleep Medicine | October 16, 2017 | Volume: 13 | Issue: 10 | Pages: 1199-1203

10.5664/jcsm.6772 | PMID 28877820 Get It

Identification of Genetic Interaction with Risk Factors Using a Time-To-Event Model
Armasu, Sebastian M. , McCauley, Bryan M. , Petterson, Tanya M. , Heit, John A. , de Andrade, Mariza, Andrade, Mariza de

Mayo Clinic

International Journal of Environmental Research and Public Health | October 16, 2017 | Volume: 14 | Issue: 10 | Pages: 1228

10.3390/ijerph14101228 | PMID 29036934 Get It

Background: Certain diseases can occur with and without a trigger. We use Venous Thromboembolism (VTE) as our example to identify genetic interaction with pregnancy in women with VTE during pre- or postpartum. Pregnancy is one of the major risk factors for VTE as it accounts for 10% of maternal deaths. Methods: We performed a whole genome association analysis using the Cox Proportional Hazard (CoxPH) model adjusted for covariates to identify genetic variants associated with the time-to-event of VTE related to pre- or postpartum during the childbearing age of 18–45 years using a case-only design in a cohort of women with VTE. Women with a VTE event after 45 years of age were censored and contributed only follow-up time. Results: We identified two intragenic single nucleotide polymorphisms (SNPs) at genome-wide significance in the PURB gene located on chromosome 7, and two additional intragenic SNPs, one in the LINGO2 gene on chromosome 9 and one in RDXP2 on chromosome X. Conclusions: We showed that the time-to-event model is a useful approach for identifying potential hazard-modification of the genetic variants when the event of interest (VTE) occurs due to a risk factor (pre- or post-partum).
A CONSTANT-RATE INDICATOR-INFUSION TECHNIC FOR THE MEASUREMENT OF CENTRAL VASCULAR VOLUME IN MAN
Bowers, Dorrance, Shepherd, John T., Wood, Earl H.

Mayo Clinic

Canadian Journal of Biochemistry and Physiology | October 16, 2017 | Volume: 33 | Issue: 1 | Pages: 340-348

10.1139/y55-045 Get It

Evans blue dye was injected at a constant rate into the right ventricle or pulmonary artery of 17 subjects in 21 experiments. The consequent arterial dilution patterns were recorded continuously by a cuvette oximeter connected to an indwelling needle in the radial artery. From these dilution patterns the amount and concentration of dye in the intravascular space between the injecting and sampling sites were determined when an equilibrium concentration was attained. From these dimensions the "central vascular volume" was calculated. The values for the central vascular volume thus derived showed agreement with those determined in near-simultaneous estimations by Hamilton's modification of Stewart's method. The values for the "lung blood volumes" by the Newman method in these subjects were systematically smaller than the values for the central vascular volume.
Measurement of Murine Single‐Kidney Glomerular Filtration Rate Using Dynamic Contrast‐Enhanced MRI
Mishra, Prasanna K. , Lerman, Lilach O. , Jiang, Kai , Macura, Slobodan I, Jiang, Kai, Tang, Hui Ru , Macura, Slobodan

Mayo Clinic

Magnetic Resonance in Medicine | October 16, 2017 | Volume: 79 | Issue: 6 | Pages: 2935-2943

10.1002/mrm.26955 | PMID 29034514 Get It

PurposeTo develop and validate a method for measuring murine single‐kidney glomerular filtration rate (GFR) using dynamic contrast‐enhanced MRI (DCE‐MRI).MethodsThis prospective study was approved by the Institutional Animal Care and Use Committee. A fast longitudinal relaxation time (T1) measurement method was implemented to capture gadolinium dynamics (1 s/scan), and a modified two‐compartment model was developed to quantify GFR as well as renal perfusion using 16.4T MRI in mice 2 weeks after unilateral renal artery stenosis (RAS, n = 6) or sham (n = 8) surgeries. This approach was validated by comparing model‐derived GFR and perfusion to those obtained by fluorescein isothiocyanante (FITC)‐inulin clearance and arterial spin labeling (ASL), respectively, using the Pearson's and Spearman's rank correlations and Bland‐Altman analysis.ResultsThe compartmental model provided a good fitting to measured gadolinium dynamics in both normal and RAS kidneys. The proposed DCE‐MRI method offered assessment of single‐kidney GFR and perfusion, comparable to the FITC‐inulin clearance (Pearson's correlation coefficient r = 0.95 and Spearman's correlation coefficient ρ = 0.94, P < 0.0001, and mean difference −7.0 ± 11.0 μL/min) and ASL (r = 0.92 and ρ = 0.84, P < 0.0001, and mean difference 4.4 ± 66.1 mL/100 g/min) methods.ConclusionThe proposed DCE‐MRI method may be useful for reliable noninvasive measurements of single‐kidney GFR and perfusion in mice. Magn Reson Med 79:2935–2943, 2018. © 2017 International Society for Magnetic Resonance in Medicine.
Regenerative Musculoskeletal Care: Ensuring Practice Implementation
Saris, Daniël B.F. , Windt, Tommy S. de , Vonk, Luciënne A. , Krych, Aaron J. , de Windt, Tommy S , Krych, Aaron J , Vonk, Lucienne A , Terzic, André

Mayo Clinic

Clinical Pharmacology & Therapeutics | October 16, 2017 | Volume: 103 | Issue: 1 | Pages: 50-53

10.1002/cpt.883 | PMID 29034457 Get It